In the Research Article, “Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell,” by Kildisiute et al. one sample (patient PD42184), that had been erroneously labeled as a tumor without cancer cells, was a sample of a normal adrenal gland from a different child (patient PD42187) and paper (Young et al., Nat Comms 2021). A summary of the changes to the article and supplementary materials following a correction of this error are noted below.
• In the Results section under “Identification of cancer cells in neuroblastoma,” the number of fresh neuroblastoma specimens went from 21 to 20, cytotoxic agents at resection went from n=17 to n=16, pretreated cases went from 17 to 16, and intermediate risk went from n=5 to n=4.
• The heading for Fig. 2 panel A has been updated from “Tumor map: 5 tumors (Chromium 10X)” to “Tumor map: 4 tumors (Chromium 10X).”
• The accession code in the Data and Materials Availability statement has been updated from “EGAD0000100637” to “EGAD00001008345.”
• A section of the supplementary materials that described the detailed processing used to identify the tumor genotype in the normal adrenal gland mis-annotated as a tumor is no longer relevant and has been deleted.
• Line 27 of Table S1 has been corrected.
The error does not impact the conclusions of the paper as the data was not included in any analyses. The Results section, Fig. 2, the Data and Materials Availability section, and supplementary materials have been updated in the HTML and online PDF versions to reflect these changes.